| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/31/2002 | WO2002008763A2 Immunosensor |
| 01/31/2002 | WO2002008754A1 Spatially resolved enzyme-linked assay |
| 01/31/2002 | WO2002008748A2 Ion channel assay methods |
| 01/31/2002 | WO2002008743A1 Biosensor |
| 01/31/2002 | WO2002008736A1 Sensor device |
| 01/31/2002 | WO2002008727A1 Reagent delivery device and method of use |
| 01/31/2002 | WO2002008469A2 Methods, systems, and articles of manufacture for evaluating biological data |
| 01/31/2002 | WO2002008468A1 Diagnostic polymorphisms for the tgf-beta1 promoter |
| 01/31/2002 | WO2002008467A1 DIAGNOSTIC POLYMORPHISMS FOR THE ecNOS PROMOTER |
| 01/31/2002 | WO2002008466A1 A systematic approach to mechanism-of-response analyses |
| 01/31/2002 | WO2002008465A1 High-throughput glutathione s-transferase polymorphic allele assay design |
| 01/31/2002 | WO2002008464A1 Method for isolating and characterizing nucleic acid sequences |
| 01/31/2002 | WO2002008463A2 Collection of binding molecules |
| 01/31/2002 | WO2002008462A1 Method for haplotyping by mass spectrometry |
| 01/31/2002 | WO2002008461A2 A METHOD AND AN ALGORITHM FOR mRNA EXPRESSION ANALYSIS |
| 01/31/2002 | WO2002008460A2 Methods for detection of human papillomavirus mrna |
| 01/31/2002 | WO2002008459A2 Method for detecting micro-organisms |
| 01/31/2002 | WO2002008458A1 Use of an imaging photoelectric flat sensor for evaluating biochips and imaging method therefor |
| 01/31/2002 | WO2002008455A2 Method for unraveling double-stranded nucleic acids located in a solution into single-stranded nucleic acids |
| 01/31/2002 | WO2002008454A2 Method and device for viable and nonviable prokaryotic and eukaryotic cell quantitation |
| 01/31/2002 | WO2002008453A2 Canine toxicity genes |
| 01/31/2002 | WO2002008450A2 Method for measuring jnk/sapk activity by phosphorylation of transcription factors |
| 01/31/2002 | WO2002008449A2 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 01/31/2002 | WO2002008447A2 Nucleic acids and methods for detecting viral infection, uncovering anti-viral drug candidates and determining drug resistance of viral isolates |
| 01/31/2002 | WO2002008445A2 Drug screening using yeast cells |
| 01/31/2002 | WO2002008425A2 Haplotypes of the adrb3 gene |
| 01/31/2002 | WO2002008424A1 Human and rat abca2 genes |
| 01/31/2002 | WO2002008420A2 A method of down-regulating gene expression |
| 01/31/2002 | WO2002008419A1 Molecular markers |
| 01/31/2002 | WO2002008414A1 Novel nucleic acid probes and method of assaying nucleic acid by using the same |
| 01/31/2002 | WO2002008399A2 Human kinases |
| 01/31/2002 | WO2002008396A2 Human proteases |
| 01/31/2002 | WO2002008390A2 Bovine wasting syndrome vaccine |
| 01/31/2002 | WO2002008388A2 Stem cell-like cells |
| 01/31/2002 | WO2002008386A2 Materials and methods for the enhancement of effective root nodulation in legumes |
| 01/31/2002 | WO2002008381A2 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia |
| 01/31/2002 | WO2002008290A1 Dog melanin-concentrating hormone receptor |
| 01/31/2002 | WO2002008286A2 Zinc finger domain recognition code and uses thereof |
| 01/31/2002 | WO2002008285A2 Il-17 molecules and uses thereof |
| 01/31/2002 | WO2002008271A1 Novel fibroblast growth factor (fgf23) and methods for use |
| 01/31/2002 | WO2002008267A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/31/2002 | WO2002008266A2 Complete nucleotide sequence of staphylococcus aureus ribosomal protein s16 gene and methods for the identification of antibacterial substances |
| 01/31/2002 | WO2002008264A2 Papillomavirus infected epithelial cells and methods of producing infectious papillomavirus in epithelial cells and uses thereof |
| 01/31/2002 | WO2002008262A2 Bstp-5 proteins and related reagents and methods of use thereof |
| 01/31/2002 | WO2002008261A2 Bstp-trans protein and related reagents and methods of use thereof |
| 01/31/2002 | WO2002008257A2 Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof |
| 01/31/2002 | WO2002008255A2 Cell cycle proteins and mitosis-associated molecules |
| 01/31/2002 | WO2002008253A2 A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY |
| 01/31/2002 | WO2002008252A2 Novel protein containing ring finger domaine r1p4 |
| 01/31/2002 | WO2002008242A1 Nucleic acids comprising regions of the rat peg-3 promoter and uses thereof |
| 01/31/2002 | WO2002008241A2 Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same |
| 01/31/2002 | WO2002007821A1 Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity |
| 01/31/2002 | WO2002007780A2 Methods for identifying therapeutic targets |
| 01/31/2002 | WO2002007778A1 Composition for determining the lactase activity |
| 01/31/2002 | WO2002007747A1 Methods of modulating fibrosis |
| 01/31/2002 | WO2001080873A3 Thrombopoietin receptor modulating peptide |
| 01/31/2002 | WO2001079485A3 Direct isolation of transposon insertions tagging transcribed portions of genes |
| 01/31/2002 | WO2001077321A3 Identification of a human gaba transporter |
| 01/31/2002 | WO2001075175A8 Manganese superoxide dismutase gene polymorphism for predicting cancer susceptibility |
| 01/31/2002 | WO2001073109A9 Continuous process for manufacture of disposable electro-chemical sensor |
| 01/31/2002 | WO2001068120A3 Uses of bombesin receptor 3 |
| 01/31/2002 | WO2001065255A3 Biosynthetic carbohydrate-deficient transferrin references |
| 01/31/2002 | WO2001063284A9 Internal standards and controls for multiplexed assay |
| 01/31/2002 | WO2001062940A3 New phosphodiesterase type 7b |
| 01/31/2002 | WO2001062784A3 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 01/31/2002 | WO2001051654A3 Methods and kits for identifying elite event gat-zm1 in biological samples |
| 01/31/2002 | WO2001049883A3 Amplification based polymorphism detection |
| 01/31/2002 | WO2001049247A3 Assays for analytes and enzymes practiced in the presence of nad and nadp analogues, and related assay kits |
| 01/31/2002 | WO2001048485A3 Selecting library members capable of binding to epitopes |
| 01/31/2002 | WO2001044811A3 Plasminogen activator assay involving an elastase inhibitor |
| 01/31/2002 | WO2001038550A3 Methods for altering the expression of hyphal-specific genes |
| 01/31/2002 | WO2001038503A3 Novel human protein kinases and protein kinase-like enzymes |
| 01/31/2002 | WO2001036605A3 2786, a human aminopeptidase |
| 01/31/2002 | WO2001031343A3 Diagnosis and therapy of cancer using sgp28-related molecules |
| 01/31/2002 | WO2001029252A3 A method for the generation of repeat-depleted dna |
| 01/31/2002 | WO2001026536A3 Methods of diagnosing and treating hepatic cell proliferative disorders |
| 01/31/2002 | WO2001025477A3 Kinase and phosphatase assays |
| 01/31/2002 | WO2001021836A3 Molecules for diagnostics and therapeutics |
| 01/31/2002 | WO2001012859A3 Detection of differences in nucleic acids by inhibition of spontaneous dna branch migration |
| 01/31/2002 | WO2001008634A3 Polynucleotide encoding a human serine protease |
| 01/31/2002 | WO2000068434A3 Multiple tag analysis |
| 01/31/2002 | WO2000066787A3 Growth hormone-regulatable liver genes and proteins, and uses thereof |
| 01/31/2002 | WO2000060919B1 Anchored strand displacement amplification on an electronically addressable microchip |
| 01/31/2002 | WO2000060124A3 Fixed address analysis of sequence tags |
| 01/31/2002 | WO2000060114A3 Polynucleotide sequencing using a helicase |
| 01/31/2002 | WO2000049173A3 Method and sample support system for separating and processing substances in situ |
| 01/31/2002 | WO2000047219A3 Methods and reagents for treating glucose metabolic disorders |
| 01/31/2002 | WO2000046232A9 Primer extension methods for production of high specific activity nucleic acid probes |
| 01/31/2002 | US20020013954 Whole-body optical imaging of gene expression and uses thereof |
| 01/31/2002 | US20020013662 Pharmacokinetic-based drug design tool and method |
| 01/31/2002 | US20020013457 Cylindrical fluid flow passageways |
| 01/31/2002 | US20020013456 Cortistatin: neuropeptides, compositions and methods |
| 01/31/2002 | US20020013372 Pharmacophore models for the identification of the CYP2D6 inhibitory potency of selective serotonin reuptake inhibitors |
| 01/31/2002 | US20020013250 The 1,2-dioxetane; a polymeric enhancer which is either an ammonium or phosphonium salt of a polyvinylbenzyl chloride and an aqueous enzyme diluent or stabilizer; detection of phosphatase, beta-galactosidase, and cholinesterase |
| 01/31/2002 | US20020012996 Mutating genes; mix cell and vector, transform mammalian cells, recover cells |
| 01/31/2002 | US20020012992 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 01/31/2002 | US20020012984 Genetic engineering |
| 01/31/2002 | US20020012972 Optimally labeled oligonucleotides |
| 01/31/2002 | US20020012971 Containing polymer |
| 01/31/2002 | US20020012970 Amplification of nucleotide sequences; provide mix which contains nucleotide sequences and polymerase, amplify nucleotide sequences, recover nucleotide sequences |